BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23387431)

  • 1. Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review.
    Bates AS; Davis CR; Takwale A; Knepil GJ
    Br J Dermatol; 2013 Jun; 168(6):1187-94. PubMed ID: 23387431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
    Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
    J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
    Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
    Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Spanish version of the Skin Cancer Index: a questionnaire for measuring quality of life in patients with cervicofacial nonmelanoma skin cancer.
    de Troya-Martín M; Rivas-Ruiz F; Blázquez-Sánchez N; Fernández-Canedo I; Aguilar-Bernier M; Repiso-Jiménez JB; Toribio-Montero JC; Jones-Caballero M; Rhee J
    Br J Dermatol; 2015 Jan; 172(1):160-8. PubMed ID: 24910357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
    Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
    Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in non-melanoma skin cancer.
    Gaulin C; Sebaratnam DF; Fernández-Peñas P
    Australas J Dermatol; 2015 Feb; 56(1):70-6. PubMed ID: 25196191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life assessment in patients with nonmelanoma skin cancer - psychometric validation of the EORTC QLQ-C30 questionnaire.
    Müller K; Karrer S; Szeimies RM; Steinbauer J; Kohl E; Steinbauer D; Zeman F; Berneburg M; Koller M
    J Dtsch Dermatol Ges; 2017 Nov; 15(11):1090-1100. PubMed ID: 29106018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
    Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the facial skin care index: a health-related outcomes index for skin cancer patients.
    Matthews BA; Rhee JS; Neuburg M; Burzynski ML; Nattinger AB
    Dermatol Surg; 2006 Jul; 32(7):924-34; discussion 934. PubMed ID: 16875475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress.
    Radiotis G; Roberts N; Czajkowska Z; Khanna M; Körner A
    Oncol Nurs Forum; 2014 Jan; 41(1):57-65. PubMed ID: 24368239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcome measures in skin cancer.
    Black N
    Br J Dermatol; 2013 Jun; 168(6):1151. PubMed ID: 23738636
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin cancer and quality of life: assessment with the Dermatology Life Quality Index.
    Rhee JS; Matthews BA; Neuburg M; Smith TL; Burzynski M; Nattinger AB
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):525-9. PubMed ID: 15056143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Sahay AP; Bertenthal DS; Sen S; Landefeld CS
    J Invest Dermatol; 2007 Jun; 127(6):1351-7. PubMed ID: 17301830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed treatment and continued growth of nonmelanoma skin cancer.
    Alam M; Goldberg LH; Silapunt S; Gardner ES; Strom SS; Rademaker AW; Margolis DJ
    J Am Acad Dermatol; 2011 May; 64(5):839-48. PubMed ID: 21055843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structured review of patient-reported outcome measures for patients with skin cancer, 2013.
    Gibbons E; Casañas i Comabella C; Fitzpatrick R
    Br J Dermatol; 2013 Jun; 168(6):1176-86. PubMed ID: 23488455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supportive care needs and distress in patients with non-melanoma skin cancer: Nothing to worry about?
    Körner A; Garland R; Czajkowska Z; Coroiu A; Khanna M
    Eur J Oncol Nurs; 2016 Feb; 20():150-5. PubMed ID: 26236032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavior modification and risk perception in patients with nonmelanoma skin cancer.
    Rhee JS; Davis-Malesevich M; Logan BR; Neuburg M; Burzynski M; Nattinger AB
    WMJ; 2008 Apr; 107(2):62-8. PubMed ID: 18593080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life issues in nonmetastatic skin cancer.
    Burdon-Jones D; Thomas P; Baker R
    Br J Dermatol; 2010 Jan; 162(1):147-51. PubMed ID: 19796177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports.
    Abedini R; Nasimi M; Noormohammad Pour P; Moghtadaie A; Tohidinik HR
    J Cancer Educ; 2019 Aug; 34(4):755-759. PubMed ID: 29705894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UK-based prospective cohort study to anglicise and validate the FACE-Q Skin Cancer Module in patients with facial skin cancer undergoing surgical reconstruction: the PROMISCR (Patient-Reported Outcome Measure in Skin Cancer Reconstruction) study.
    Dobbs T; Hutchings HA; Whitaker IS
    BMJ Open; 2017 Sep; 7(9):e016182. PubMed ID: 28947443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.